1. Metabolic Enzyme/Protease Immunology/Inflammation MAPK/ERK Pathway NF-κB
  2. Endogenous Metabolite COX p38 MAPK NF-κB NOD-like Receptor (NLR) NO Synthase Reactive Oxygen Species (ROS) Interleukin Related
  3. MBL-1

MBL-1 是一种具有口服活性的抗炎剂。MBL-1 可从柳珊瑚来源的 Aspergillus sp. 的发酵液中分离。MBL-1 抑制 hCOX-2 蛋白的活性,其 IC50 为 5.77 μM。MBL-1 可通过抑制 MAPK/NF-κBNLRP3 信号通路,减少 NOROSIL-1βIL-18 等关键促炎介质的产生。MBL-1 对 DSS 诱导的结肠炎具有保护作用。MBL-1 可用于溃疡性结肠炎的研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

MBL-1

MBL-1 Chemical Structure

CAS No. : 1815632-13-3

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

查看 COX 亚型特异性产品:

查看 p38 MAPK 亚型特异性产品:

查看 NF-κB 亚型特异性产品:

查看 NOD-like Receptor (NLR) 亚型特异性产品:

查看 NO Synthase 亚型特异性产品:

查看 Interleukin Related 亚型特异性产品:

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

MBL-1 is an orally active anti-inflammatory agent. MBL-1 can be isolated from the fermentation broth of Aspergillus sp. derived from gorgonians. MBL-1 inhibits the activity of the hCOX-2 protein with an IC50 of 5.77 μM. MBL-1 reduces the production of key pro-inflammatory mediators such as NO, ROS, IL-1β and IL-18 by inhibiting the MAPK/NF-κB and NLRP3 signaling pathways. MBL-1 exerts a protective effect against DSS-induced colitis. MBL-1 can be used for the research of ulcerative colitis[1].

IC50 & Target[1]

Fungal Metabolite

 

hCOX-2

5.77 μM (IC50)

NLRP3

 

IL-1β

 

IL-18

 

体外研究
(In Vitro)

MBL-1 可强效抑制 hCOX-2 蛋白的活性,其 IC50 为 5.77 μM[1]
MBL-1 (0.5-50 μM; 24 h) 在 RAW 264.7、J774A.1 和 MCF-7 细胞中,浓度高达 50 μM 时无细胞毒性[1]
MBL-1 (2-30 μM; 1 h) 以剂量依赖方式抑制 LPS 刺激的 RAW 264.7 细胞中 NO 的生成[1]
MBL-1 (2-30 μM; 1 h) 呈剂量依赖性抑制 LPS 刺激的 RAW 264.7 细胞中 ROS 的产生 [1]
MBL-1 (2-30 μM; 1 h) 以剂量依赖方式抑制 LPS 刺激的 RAW 264.7 细胞中细胞因子 IL-6、IL-10 和 IL-1β 的产生[1]
MBL-1 (2-30 μM) 剂量依赖性地抑制 RAW 264.7 细胞中 LPS 诱导的 p38、ERK 和 JNK 蛋白的磷酸化[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究
(In Vivo)

MBL-1 (25-50 mg/kg;口服;每日 1 次) 对雄性 C57BL/6 J 小鼠中 DSS 诱导的急性结肠炎具有显著的剂量依赖性保护作用[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: C57BL/6 J (male, 7 weeks old, DSS-induced colitis model)[1]
Dosage: 25 mg/kg; 50 mg/kg
Administration: p.o.; once daily; 7 days
Result: Mitigated DSS-induced body weight loss in a dose-dependent manner.
Attenuated progressive elevation of DAI scores in a dose-dependent manner.
Preserved colonic length in a dose-dependent manner, with 50 mg/kg dose resulting in a statistically significant increase compared to DSS-only controls.
Alleviated mucosal ulceration, preserved epithelial integrity, and reduced inflammatory cell infiltration; 50 mg/kg dose resulted in a statistically significant reduction in histological scores compared to DSS-only controls.
分子量

438.47

Formula

C25H26O7

CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
MBL-1
目录号:
HY-N6189
需求量: